IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 35, 2015, Pages 11024-11029

  Barone, Francesca ^a   Nayara, Saba ^a   Camposa, Joana ^a   Cloakea, Thomas ^a   Withers, David R ^a   Toellner, Kai Michael ^a   Zhang, Yang ^a   Fouser, Lynette ^b   Fisher, Benjamin ^a   Bowman, Simon ^a   Rangel Moreno, Javier ^c   De La Garcia Hernandez, Maria Luz ^c   Randall, Troy D ^d   Lucchesi, Davide ^e   Bombardieri, Michele ^e   Pitzalis, Costantino ^e   Luther, Sanjiv A ^f   Buckley, Christopher D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b PFIZER INC   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d University of Alabama at Birmingham   (United States)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Autoimmunity; Chemokines; IL 22; Sjogren's syndrome; Tertiary lymphoid organs

Indexed keywords

INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN RECEPTOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; AUTOANTIBODY; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FIBROSARCOMA CELL; IMMUNOREGULATION; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; STROMA CELL; ANIMAL; BIOSYNTHESIS; GENETICS; KNOCKOUT MOUSE; LYMPHOID TISSUE; METABOLISM; PHYSIOLOGY;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; CHEMOKINES, CXC; INTERLEUKINS; LYMPHOID TISSUE; MICE; MICE, KNOCKOUT;

EID: 84940979239     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1503315112     Document Type: Article

References (46)

1. Aloisi F, Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6(3):205-217.
2. Pitzalis C, Jones GW, Bombardieri M, Jones SA (2014) Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol 14(7):447-462.
3. Barone F, et al. (2005) Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum 52(6):1773-1784.
4. Salomonsson S, et al. (2002) Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 55(4):336-342.
5. Barone F, et al. (2008) CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: Association with reactive and malignant areas of lymphoid organization. J Immunol 180(7):5130-5140.
6. van de Pavert SA, Mebius RE (2010) New insights into the development of lymphoid tissues. Nat Rev Immunol 10(9):664-674.
7. Krautler NJ, et al. (2012) Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 150(1):194-206.
8. Martin AP, et al. (2004) A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J Immunol 173(8):4791-4798.
9. Rangel-Moreno J, et al. (2011) The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 12(7):639-646.
10. Buckley CD, Barone F, Nayar S, Bénézech C, Caamaño J (2015) Stromal cells in chronic inflammation and tertiary lymphoid organ formation. Annu Rev Immunol 33: 715-745.
11. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D (2011) CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34(1):122-134.
12. Pantelyushin S, et al. (2012) Rorãt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122(6):2252-2256.
13. Andoh A, et al. (2005) Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129(3):969-984.
14. Colonna M (2009) Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31(1):15-23.
15. Dudakov JA, Hanash AM, van den Brink MR (2015) Interleukin-22: Immunobiology and pathology. Annu Rev Immunol 33:747-785.
16. Puel A, et al. (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207(2):291-297.
17. Lavoie TN, Stewart CM, Berg KM, Li Y, Nguyen CQ (2011) Expression of interleukin-22 in Sjögren's syndrome: Significant correlation with disease parameters. Scand J Immunol 74(4):377-382.
18. Ciccia F, et al. (2013) Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. Ann Rheum Dis 72(5):782-783.
19. Bombardieri M, et al. (2012) Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol 189(7):3767-3776.
20. Peduto L, et al. (2009) Inflammation recapitulates the ontogeny of lymphoid stromal cells. J Immunol 182(9):5789-5799.
21. Sonnenberg GF, Fouser LA, Artis D (2010) Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. Adv Immunol 107:1-29.
22. Sonnenberg GF, Fouser LA, Artis D (2011) Border patrol: Regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12(5): 383-390.
23. Kirchberger S, et al. (2013) Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 210(5):917-931.
24. Ciccia F, et al. (2012) Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis Rheum 64(6):1869-1878.
25. Ota N, et al. (2011) IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol 12(10):941-948.
26. Kim KW, et al. (2012) Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum 64(4):1015-1023.
27. Marchesi F, et al. (2009) CXCL13 expression in the gut promotes accumulation of IL- 22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol 2(6):486-494.
28. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG (2000) BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12(5):471-481.
29. Ansel KM, et al. (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406(6793):309-314.
30. Luther SA, et al. (2002) Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 169(1):424-433.
31. Marinkovic T, et al. (2006) Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J Clin Invest 116(10):2622-2632.
32. + lymphoid tissue inducer cells. Mucosal Immunol 7(3):602-614.
33. Fleige H, et al. (2014) IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs. J Exp Med 211(4):643-651.
34. Peters A, et al. (2011) Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35(6):986-996.
35. Beltman JB, Allen CD, Cyster JG, de Boer RJ (2011) B cells within germinal centers migrate preferentially from dark to light zone. Proc Natl Acad Sci USA 108(21): 8755-8760.
36. Allen CD, et al. (2004) Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 5(9):943-952.
37. Lötzer K, et al. (2010) Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling. Arterioscler Thromb Vasc Biol 30(3):395-402.
38. Rantapää-Dahlqvist S, et al. (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48(10):2741-2749.
39. Bos WH, et al. (2010) Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: A prospective cohort study. Ann Rheum Dis 69(3):490-494.
40. Barra L, et al. (2013) Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients. Arthritis Rheum 65(6):1439-1447.
41. Bombardieri M, et al. (2007) Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome. J Immunol 179(7):4929-4938.
42. Humby F, et al. (2009) Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 6(1):e1.
43. Sisto M, et al. (2007) Autoantibodies from Sjögren's syndrome trigger apoptosis in salivary gland cell line. Ann N Y Acad Sci 1108:418-425.
44. Mazzucchelli L, et al. (1999) BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 104(10): R49-R54.
45. Ma HL, et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118(2):597-607.
46. Barone F, Patel P, Sanderson JD, Spencer J (2009) Gut-associated lymphoid tissue contains the molecular machinery to support T-cell-dependent and T-cell-independent class switch recombination. Mucosal Immunol 2(6):495-503.